罗斯马林斯 (Rosmarinus officinalis) 树叶提取物对 KB 细胞系的抗癌作用
V R Pradeep1, S Menaka1, Vasugi Suresh1
1Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS) Saveetha University, Chennai, IND.
Cureus
|March 14, 2024
概括
迷香提取物 (Rosmarinus officinalis) 通过降低癌细胞活力和降低KB细胞系MMP-9和TIMP-1基因表达的调节,显示出抗癌作用.
科学领域:
- 药理学和自然产品化学化学
- 癌症生物学和治疗方法
- 分子生物学分子生物学
背景情况:
- 药用植物,特别是花 (Rosmarinus officinalis) 正因其治疗潜力而引起人们的注意.
- 罗斯马林斯 (Rosmarinus officinalis) 原产于地中海,被广泛种植并研究其生物活性化合物.
- 人类上皮癌 (KB) 细胞系对化疗剂敏感,为癌症研究提供了宝贵的模型.
研究的目的:
- 评估Rosmarinus officinalis叶提取物在人类上皮癌 (KB) 细胞系上的抗癌活性.
- 评估迷香提取物对癌细胞活力和基因表达的影响.
- 探索Rosmarinus officinalis作为合成抗癌药物的潜在天然替代品.
主要方法:
- 准备和应用Rosmarinus officinalis叶提取物到KB细胞系.
- 使用MTT试验进行细胞活力评估 (3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium化物).
- 通过RT-PCR (实时聚合酶连锁反应) 对矩阵金属蛋白酶-9 (MMP-9) 和金属蛋白酶-1 (TIMP-1) 组织抑制剂mRNA的基因表达分析.
主要成果:
- 增加迷香提取物的度显著降低了恶性KB细胞中的细胞活力.
- 罗斯马林斯 (Rosmarinus officinalis) 提取物证明了对亡信号通路的影响.
- 通过RT-PCR分析发现,在用迷香提取物治疗后,MMP-9和TIMP-1mRNA表达率下降.
结论:
- 罗斯马林斯 (Rosmarinus officinalis) 对抗KB细胞系具有显著的抗癌特性.
- 提取物影响了参与癌症进展和亡的关键基因.
- 生物制备的Rosmarinus officinalis作为天然抗癌剂具有前景,可能补充或取代合成化疗药物.
关键词:
这是一种抗癌药物.卡博普拉丁是碳酸盐中的一种.西斯普拉丁 (cisplatin) 是一种制剂.人类上皮细胞癌 (Human Epithelial Carcinoma) 是一种kb 细胞系的细胞系.这就是MMP-9基因.这是一个MTT测试.在实时PCR中进行实时PCR.罗斯马林斯 (Rosmarinus officinalis) 是一个植物.诱导瘤的金属蛋白质.更多相关视频
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.6K
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
12.3K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
